| R million | At disposal date |
|
|---|---|---|
| Property, plant and equipment | 8 257 | |
| Intangible assets | 9 023 | |
| Inventories | 8 461 | |
| Debtors and short-term loans | 5 979 | |
| Cash and cash equivalents | 2 318 | |
| Other assets | 1 438 | |
| Deferred taxation | (3 300) | |
| Trade and other payables | (7 938) | |
| Bank overdraft | (1 550) | |
| Other liabilities | (1 744) | |
| Non-controlling interest | (12 239) | |
| Carrying value of net assets disposed | 8 705 | |
| Consideration received | 13 079 | |
| Cash consideration received from Namibia Breweries | 1 564 | |
| Cash on shares disposed to Heineken, net of costs | 1 245 | |
| Exchanged for investment in Heineken Beverages | 10 270 | |
| Profit on disposal | 4 374 | |
| Cash inflow on disposal | 2 041 | |
| Cash and cash equivalents and bank overdrafts of business disposed | (768) | |
| Cash consideration received | 2 809 | |
|
3. |
Headline earnings reconciliation |
| R million | 30 June 2023 | 30 June 2022 Restated |
|
|---|---|---|---|
| Continuing operations | |||
| Net profit for the year attributable to equity holders (earnings) | 5 836 | 12 445 | |
| – Impairment of equity accounted investments(1) | 58 | 193 | |
| – Reversal of impairment of equity accounted investments(1) | (5) | (361) | |
| – Impairment of property, plant and equipment | 70 | 100 | |
| – Reversal of impairment of property, plant and equipment | (35) | (253) | |
| – Impairment of intangible and other assets | 462 | 162 | |
| – Profit on sale and dilution of equity accounted investments | (321) | (395) | |
| – Loss on sale and dilution of equity accounted investments | 2 | 1 | |
| – Profit on disposal of property, plant and equipment | (78) | (27) | |
| – Loss on disposal of property, plant and equipment | 62 | 14 | |
| – Recycling of foreign currency translation reserves | (10) | – | |
| – Non-headline earnings items included in equity accounted earnings of equity accounted investments | 984 | (6 181) | |
| – Profit on disposal of property, plant and equipment | (18) | (59) | |
| – Profit on sale of investments(2) | (67) | (6 298) | |
| – Loss on sale of investments | – | 1 | |
| – Impairment of investments, assets and goodwill | 1 069 | 190 | |
| – Other headline earnings adjustable items | – | (15) | |
| – Taxation effect of adjustments | (13) | 126 | |
| – Non-controlling interest | (370) | (8) | |
| Headline earnings from continuing operations | 6 642 | 5 816 | |
| Discontinued operations | |||
| Net profit for the year attributable to equity holders (earnings) | 3 788 | 694 | |
| – Impairment of property, plant and equipment | – | 6 | |
| – Profit on disposal of property, plant and equipment | (9) | (56) | |
| – Loss on disposal of property, plant and equipment | 36 | 9 | |
| – Loss on disposal of intangible assets | – | (12) | |
| – Profit on disposal of subsidiary(3) | (4 374) | – | |
| – Recycling of foreign currency translation reserves | 23 | – | |
| – Non-headline earnings items included in equity accounted earnings of equity accounted investments | |||
| – Profit on disposal of property, plant and equipment | – | (8) | |
| – Taxation effect of adjustments | 607 | 9 | |
| – Non-controlling interest | 343 | 36 | |
| Headline earnings from discontinued operations | 414 | 678 | |
| Total headline earnings from continuing and discontinued operations | 7 056 | 6 494 | |
Headline earnings, adjusted for corporate actions, reconciliationCorporate actions such as the unbundling, restructuring, acquisition and disposal of investments may result in non-recurring items or items that distort comparability, being recognised in the income statement that may not be excluded from the calculation of headline earnings as per the HEPS circular 1/2023. Headline earnings is then adjusted for these items (net of tax), being transaction and restructuring costs; acquisition and disposal-related gains or losses (inter alia foreign exchange gains or losses); income or losses that were not accounted for the full reporting period (inter alia consolidated or equity accounted income or losses until the date of unbundling, restructuring or disposal); and income or losses that were not accounted for on a consistent basis between reporting periods (inter alia to consolidate or to equity account as opposed to dividend income from investments recognised at fair value through other comprehensive income). In these instances, the Group discloses an alternative earnings measure excluding these items in order to promote comparability between reporting periods. For the current and comparative years, these corporate actions and their impact on headline earnings include:
Headline earnings adjusted for the above-mentioned corporate actions is as follows: |
4. |
Earnings and dividends |
5. |
Investments – Equity accounted |
| R million | 30 June 2023 |
30 June 2022 |
|
|---|---|---|---|
| Associates | 27 973 | 43 317 | |
| Joint ventures | 48 472 | 7 454 | |
| Investments – Equity accounted | 76 445 | 50 771 | |
| Loans to equity accounted investments – current | 35 | 15 | |
| 76 480 | 50 786 | ||
| Equity accounted investments reconciliation | |||
| Carrying value at the beginning of the year | 50 786 | 50 301 | |
| Share of net attributable profit | 3 472 | 10 980 | |
| Dividends received | (1 459) | (1 687) | |
| Grindrod unbundled(1) | (1 649) | – | |
| Investments made(2) | 18 034 | 2 163 | |
| Business disposed | (806) | – | |
| Discovery dividend in specie(3) | – | (8 561) | |
| Momentum Metropolitan dividend in specie(3) | – | (2 056) | |
| Exchange rate differences | 7 087 | (244) | |
| Grindrod Shipping transferred to non-current assets held for sale/disposed of(4) | – | (1 055) | |
| Net impairments | (50) | 168 | |
| Net allowances on loans | – | 1 | |
| Equity accounted movements on reserves | 1 388 | 729 | |
| Other movements | (323) | 47 | |
| Carrying value at the end of the year | 76 480 | 50 786 | |
Net impairments of equity accounted investments and loss allowances on loansReversal of impairments/(impairments) were recognised for the following investments: |
| R million | 30 June 2023 |
30 June 2022 |
|
|---|---|---|---|
| Business Partners(1) | – | (193) | |
| Grindrod(2) | – | 361 | |
| Other impairments and loss allowances | (50) | 1 | |
| Other impairments and loss allowances | (50) | 169 | |
At 30 June 2023, the fair value of the investment in Mediclinic was R47 268 million (2022: listed market value R29 568 million), which exceeded the carrying value of R41 050 million (2022: R26 681 million). Included in the carrying value of the investment is an impairment of R3 898 million which arose following regulatory changes in the investments’ Switzerland business that affected its profitability since the 2019 financial year. Subsequently, the business was also severely impacted by the Covid-19 pandemic. While the Switzerland business is adapting to the new business environment and is recovering after the pandemic, its profitability has not yet improved sufficiently to warrant a reversal of the impairment. Share of after-tax profit of equity accounted investments |
6. |
Investments at fair value through other comprehensive income (FVOCI) |
| R million | 30 June 2023 |
30 June 2022 |
|
|---|---|---|---|
| Carrying value at the beginning of the year | 20 650 | 14 342 | |
| Fair value adjustments for the year(1) | 1 657 | (740) | |
| Investments made | 306 | 243 | |
| Discovery received as a dividend in specie(2) | – | 8 561 | |
| Momentum Metropolitan received as dividend in specie(2) | – | 2 056 | |
| Exchange rate differences | 393 | 352 | |
| Disposals(3) | (415) | (2 966) | |
| Business disposed | (38) | – | |
| Transfer to assets held for sale(3) | – | (1 198) | |
| Other movements | 11 | – | |
| Carrying value at the end of the year | 22 564 | 20 650 | |
|
12. |
Fair value remeasurementsThe following methods and assumptions are used to determine the fair value of each class of financial instruments:
Financial instruments measured at fair value are disclosed by level of the following fair value hierarchy:
The following table illustrates the fair values of financial assets and liabilities that are measured at fair value, by hierarchy level: |
| R million | Level 1 | Level 2 | Level 3 | Level 4 | |
|---|---|---|---|---|---|
| 30 June 2023 | |||||
| Assets | |||||
| Non-current assets | |||||
| Financial assets at FVOCI | 20 246 | 3 | 2 315 | 22 564 | |
| Financial assets at FVPL | – | – | 150 | 150 | |
| Current assets | |||||
| Financial assets at FVPL | – | 29 | – | 29 | |
| Investment in money market funds | 4 582 | – | – | 4 582 | |
| 24 828 | 32 | 2 465 | 27 325 | ||
| Liabilities | |||||
| Current instruments at FVPL | – | 6 | – | 6 | |
| Hedge derivatives | – | 92 | – | 92 | |
| – | 98 | – | 98 | ||
| 30 June 2022 | |||||
| Assets | |||||
| Non-current assets | |||||
| Financial assets at FVOCI | 18 248 | – | 2 402 | 20 650 | |
| Financial assets at FVPL | – | – | 242 | 242 | |
| Current assets | |||||
| Financial assets at FVPL | – | 78 | – | 78 | |
| Investment in money market funds | 5 700 | – | – | 5 700 | |
| 23 948 | 78 | 2 644 | 26 670 | ||
| Liabilities | |||||
| Current instruments at FVPL | – | 33 | – | 33 | |
| Hedge derivatives | – | 51 | – | 51 | |
| – | 84 | – | 84 | ||
The following table illustrates the reconciliation of the carrying value of level 3 assets at the beginning and end of the year: |
| R million | Financial assets at FVOCI |
Financial assets at FVPL |
Total | |
|---|---|---|---|---|
| Assets | ||||
| Balances at 1 July 2022 | 2 402 | 242 | 2 644 | |
| Additions | 306 | – | 306 | |
| Disposals | (415) | – | (415) | |
| Business disposed | (38) | – | (38) | |
| Exchange rate adjustment | 203 | 35 | 238 | |
| Fair value adjustments through other comprehensive income | (143) | – | (143) | |
| Fair value adjustments through profit and loss | – | (127) | (127) | |
| Balances at 30 June 2023 | 2 315 | 150 | 2 465 | |
13. |
Segment revenue |
| Year ended 30 June | |||
|---|---|---|---|
| R million | 2023 | 2022 Restated |
|
| Consumer products | |||
| RCL Foods(1) | 37 616 | 32 038 | |
| Capevin(1) | 2 897 | 2 620 | |
| Siqalo Foods | 3 748 | 3 546 | |
| Industrial | |||
| Wispeco | 3 813 | 3 598 | |
| Other | 77 | 74 | |
| Total revenue from continuing operations | 48 151 | 41 876 | |
| Disaggregated revenue information | |||
| RCL Foods(1) | |||
| RCL Foods Value-Added Business | 24 760 | 21 156 | |
| Groceries | 5 034 | 4 732 | |
| Baking | 8 625 | 7 423 | |
| Sugar | 11 101 | 9 001 | |
| Rainbow | 13 464 | 11 385 | |
| Sales between RCL Foods’ business units | (639) | (530) | |
| Group | 198 | 190 | |
| 37 783 | 32 201 | ||
| Capevin(1) | |||
| Spirits | 2 632 | 2 290 | |
| Other | 265 | 330 | |
| 2 897 | 2 620 | ||
| Siqalo Foods | |||
| Spreads | 3 748 | 3 546 | |
| Wispeco | |||
| Extrusions and related products | 3 208 | 3 050 | |
| Other | 605 | 548 | |
| 3 813 | 3 598 | ||
| Other | 77 | 74 | |
| Elimination of intersegment revenue | (167) | (163) | |
| Total revenue from continuing operations | 48 151 | 41 876 | |
|
||||||||||
14. |
Related party transactionsMediclinic Group Limited (Mediclinic)On 26 September 2022, the Mediclinic shareholders voted in favour of a cash offer by Manta Bidco Limited (Bidco), a newly formed company which is jointly owned by Remgro and MSC Mediterranean Shipping Company SA (MSC), to acquire the entire issued and to be issued ordinary share capital of Mediclinic, other than the Mediclinic shares Remgro already owned (the Mediclinic acquisition). The last conditions precedent in respect of the Mediclinic acquisition were met during May 2023 and on 6 June 2023 Mediclinic shareholders received 501 pence per Mediclinic share, being the offer price of 504 pence per Mediclinic share less the dividend of 3 pence per Mediclinic share that was paid on 26 August 2022. To enable the Mediclinic acquisition, Remgro sold its existing 328 497 888 Mediclinic shares (representing an interest of 44.6%) to Bidco in exchange for shares in Bidco and subscribed for further shares in Bidco amounting to £221 million (representing an additional indirect interest in Mediclinic of 5.4% and approximately 50% of Bidco’s transaction costs). MSC also subscribed for shares in Bidco amounting to £1 867 million (representing an indirect interest in Mediclinic of 50% and 50% of Bidco’s transaction costs). As both Remgro’s investments in Mediclinic (associate) and Bidco (joint venture) are accounted for using the equity method, Remgro effectively ceased the equity accounting of its 44.6% interest in Mediclinic at the end of May 2023 and commenced with the equity accounting of its 50% indirect interest in Mediclinic, through its 50% interest in Bidco. Bidco made fair value adjustments to Mediclinic’s statement of financial position when it acquired its 100% stake in Mediclinic. These fair value adjustments mainly relate to the Mediclinic properties and the Mediclinic brand in South Africa and the Middle East. Going forward, Remgro will account for depreciation and amortisation on these additional assets identified, inside headline earnings. The additional depreciation and amortisation will only relate to Remgro’s newly acquired 5.4% indirect interest in Mediclinic as Remgro already owned the 44.6% interest. Distell Group Holdings Limited (Distell)On 15 February 2022, the Distell shareholders approved the combination of the Heineken Southern African business, including an interest in Namibia Breweries, with the bulk of the Distell business (consisting of its cider, other RTDs and spirits and wine business) in Heineken Beverages, a new unlisted entity controlled by Heineken. The transaction included the unbundling by Distell of the unlisted shares in Distell’s subsidiary, Capevin, which holds Distell’s remaining assets, including its Scotch whisky business. The transaction, which was implemented on 26 April 2023, also included an offer by Heineken Beverages to Distell shareholders to acquire their Distell shares for R165 per share and/or unlisted shares in Heineken Beverages, or a combination thereof (subject to a potential scaling back of the issue of Heineken Beverages shares to Distell shareholders, electing to receive Heineken Beverages shares, to ensure a 65% shareholding by Heineken in Heineken Beverages), and an offer by Heineken to Distell shareholders to acquire their Capevin shares for R15 per share. Remgro elected to receive Heineken Beverages shares for its Distell shares. However, as a result of the scale back, Remgro sold 7 607 803 Distell shares to Heineken Beverages on 26 April 2023 for R1 255 million (being R165 per Distell share) and exchanged the remaining 62 242 453 Distell shares for 62 242 453 Heineken Beverages shares (representing an interest of 15.5%). Following the implementation of the transaction, Remgro acquired a further 13 218 475 shares in Heineken Beverages for R2 181 million (or R165 per share excluding transaction costs), in a series of off-market transactions. These transactions increased Remgro’s interest in Heineken Beverages to 18.8%. As Remgro has significant influence over Heineken Beverages through its board representation, the investment is classified as an associate and is accounted for using the equity method. Both Remgro and Heineken Beverages made fair value adjustments to the statements of financial position of Heineken Beverages and Distell and Namibia Breweries, respectively. These fair value adjustments mainly relate to the various brands held by these companies (inter alia Savanna, Heineken, Amstel, Windhoek Lager and Amarula), as well as Distell’s properties and inventory. Going forward, Remgro will account for depreciation and amortisation on these additional assets identified, inside headline earnings. Remgro did not accept the cash offer made by Heineken for the Capevin shares and, as a result, Remgro’s shareholding in Capevin mirrors the shareholding that was previously held in Distell, being an economic interest of 31.4% and a voting interest of 55.9%. Therefore, the Capevin investment remains classified as a subsidiary. Community Investment Ventures Holdings Proprietary Limited (CIVH)As previously reported, Vodacom Proprietary Limited (Vodacom) will, through a combination of assets of approximately R4.2 billion and cash of at least R6.0 billion, acquire up to 40% of the ordinary shares of a newly created wholly owned subsidiary of CIVH (namely Maziv Proprietary Limited (Maziv)). Maziv holds inter alia CIVH’s current interests in Vumatel and DFA. As a result of the proposed transaction, Remgro’s indirect interest in DFA and Vumatel will dilute with the entrance of Vodacom as a shareholder, however Remgro will also obtain an indirect interest in the assets contributed by Vodacom. During August 2023, The Competition Commission South Africa announced its non-binding recommendation to the Competition Tribunal, to prohibit the proposed transaction. Remgro and CIVH remain committed to the proposed transaction and firmly believe that, should the implementation of the proposed transaction ultimately be permitted by the Competition Tribunal, it will deliver significant benefits to South African consumers and the broader economy. Grindrod Limited (Grindrod)On 17 October 2022 Remgro unbundled its investment in Grindrod to its shareholders as a dividend in specie amounting to R1 640 million, in the ratio of 30.70841 Grindrod shares for every 100 Remgro shares held. |
|||||||||
15. |
Events after year-endRCL Foods: Sale of Vector LogisticsThe sale of the RCL Foods’ Vector Logistics segment, which has been presented as held for sale at 30 June 2023, was finalised on 28 August 2023, resulting in a net cash receipt of R1 307 million, comprising the purchase price of R1 250 million, plus interest and less the post-tax share option liability of Vector Logistics. The purchase price is subject to certain EBITDA targets being met, which may result in a future upwards or downwards adjustment of up to R100 million in the purchase price. The transition of Vector Logistics out of RCL Foods and its shared services platform is expected to take place over the next 12 months. Capevin: Termination of Gordon’s Gin distribution agreementThe Gordon’s Gin and Pimm’s No1 Cup distribution agreement, which has been presented as held for sale at 30 June 2023, was included in the remaining assets that were allocated to Capevin as part of the Distell/Heineken transaction. On 19 July 2023 the Competition Commission of South Africa approved the proposed transaction, whereby this distribution agreement will be terminated in favour of the brand owner Diageo, without conditions. The consideration amounts to R1 billion, of which R700 million was received on 4 August 2023. The outstanding amount of R300 million is payable over the next ten months subject to achieving certain thresholds relating to the continued supply and manufacturing of the products by Capevin to Diageo. Other than the above-mentioned events, there were no other significant events subsequent to 30 June 2023. |
|||||||||
16. |
Discontinued operations
|
| 30 June 2023 | |||||
|---|---|---|---|---|---|
| R million | Distel | Vector Logistics |
Gordon’s Gin |
Total | |
| Profit for the year from discontinued operations: | |||||
| Revenue | 27 296 | 3 067 | 2 329 | 32 692 | |
| Inventory expenses | (17 990) | (597) | (1 864) | (20 451) | |
| Staff costs | (2 892) | (1 124) | (16) | (4 032) | |
| Depreciation | (669) | (150) | – | (819) | |
| Other net operating expenses | (4 181) | (1 041) | (224) | (5 446) | |
| Trading profit | 1 564 | 155 | 225 | 1 944 | |
| Dividend income | 3 | 6 | – | 9 | |
| Interest received | 108 | 31 | – | 139 | |
| Finance costs | (198) | (111) | – | (309) | |
| Loss allowances on loans | (22) | – | – | (22) | |
| Consolidated profit before tax | 1 455 | 81 | 225 | 1 761 | |
| Taxation | (478) | (17) | (61) | (556) | |
| Consolidated profit after tax | 977 | 64 | 164 | 1 205 | |
| Share of after-tax profit of equity accounted investments | 164 | 12 | – | 176 | |
| Net profit for the year from discontinued operations | 1 141 | 76 | 164 | 1 381 | |
| Profit on sale of investments | 4 374 | – | – | 4 374 | |
| Reserves recycled | (23) | – | – | (23) | |
| Taxation | (615) | – | – | (615) | |
| Total profit for the year from discontinued operations | 4 877 | 76 | 164 | 5 117 | |
| Attributable to: | |||||
| Equity holders | 3 677 | 59 | 52 | 3 788 | |
| Non-controlling interest | 1 200 | 17 | 112 | 1 329 | |
| Other comprehensive income for the year from discontinued operations: | |||||
| Net profit for the year | 4 877 | 76 | 164 | 5 117 | |
| Exchange rate adjustments | (174) | 3 | – | (171) | |
| Fair value adjustments | 4 | – | – | 4 | |
| Reclassification of other comprehensive income to the income statement | 22 | – | – | 22 | |
| Remeasurement of post-employment benefit obligations | (24) | 2 | – | (22) | |
| Deferred taxation on remeasurement of post-employment benefit obligations | 6 | – | – | 6 | |
| Total comprehensive income | 4 711 | 81 | 164 | 4 956 | |
| Attributable to: | |||||
| Equity holders | 3 623 | 63 | 52 | 3 738 | |
| Non-controlling interest | 1 088 | 18 | 112 | 1 218 | |
| Cash flows for the year from discontinued operations: | |||||
| Operating activities | (457) | (197) | 15 | (639) | |
| Investment activities | 184 | (179) | – | 5 | |
| Financing activities | (1 044) | (126) | – | (1 170) | |
| Net increase/(decrease) in cash generated | (1 317) | (502) | 15 | (1 804) | |
| 30 June 2022 | |||||
|---|---|---|---|---|---|
| Distell | Vector Logistics |
Gordon’s Gin |
Total | ||
| Profit for the year from discontinued operations: | |||||
| Revenue | 29 202 | 2 706 | 2 312 | 34 220 | |
| Inventory expenses | (18 914) | (451) | (1 765) | (21 130) | |
| Staff costs | (2 756) | (1 084) | – | (3 840) | |
| Depreciation | (769) | (179) | – | (948) | |
| Other net operating expenses | (4 287) | (846) | (166) | (5 299) | |
| Trading profit | 2 476 | 146 | 381 | 3 003 | |
| Dividend income | 6 | – | – | 6 | |
| Interest received | 126 | 23 | – | 149 | |
| Finance costs | (249) | (93) | – | (342) | |
| Impairment of investments, assets and goodwill | – | (6) | – | (6) | |
| Loss allowances on loans | (7) | – | – | (7) | |
| Consolidated profit before tax | 2 352 | 70 | 381 | 2 803 | |
| Taxation | (719) | (19) | (107) | (845) | |
| Consolidated profit after tax | 1 633 | 51 | 274 | 1 958 | |
| Share of after-tax profit of equity accounted investments | 181 | 13 | – | 194 | |
| Net profit for the year from discontinued operations | 1 814 | 64 | 274 | 2 152 | |
| Attributable to: | |||||
| Equity holders | 557 | 50 | 87 | 694 | |
| Non-controlling interest | 1 257 | 14 | 187 | 1 458 | |
| Other comprehensive income for the year from discontinued operations | |||||
| Net profit for the year | 1 814 | 64 | 274 | 2 152 | |
| Exchange rate adjustments | 16 | 1 | – | 17 | |
| Fair value adjustments | 37 | – | – | 37 | |
| Other comprehensive income of equity accounted investments | 2 | – | – | 2 | |
| Remeasurement of post-employment benefit obligations | 60 | – | – | 60 | |
| Deferred taxation on remeasurement of post-employment benefit obligations | (7) | – | – | (7) | |
| Total comprehensive income | 1 922 | 65 | 274 | 2 261 | |
| Attributable to: | |||||
| Equity holders | 591 | 51 | 87 | 729 | |
| Non-controlling interest | 1 331 | 14 | 187 | 1 532 | |
| Cash flows for the year from discontinued operations: | |||||
| Operating activities | 2 988 | 344 | – | 3 332 | |
| Investment activities | (1 324) | (149) | – | (1 473) | |
| Financing activities | (1 164) | (150) | – | (1 314) | |
| Net increase/(decrease) in cash generated | 500 | 45 | – | 545 | |